Posts in category: Uncategorized

When BBC journalist Rory Carson sought online consultations for a potential mental health issue, three private clinics diagnosed him with attention deficit hyperactivity disorder (ADHD). They charged between £685 and £1,095 for these consultations, which lasted between 45 and 100 minutes, and all prescribed him medication.

In utero exposure to corticosteroids and β2-adrenergic agonists appears to not be associated with most offspring neurodevelopmental outcomes, according to a study published online Oct. 24 in JAMA Network Open.

Researchers at Nagoya University in Japan have created and improved artificial intelligence (AI) designs to synthesize a candidate compound for a new gastric acid inhibitor with a better binding affinity than existing drugs. Their findings, published in Communications Biology, suggest a new way to work in tandem with AI to develop pharmaceuticals.

Researchers at Nagoya University in Japan and their collaborators have used a biomarker based on microbubbles to evaluate the success of near-infrared photoimmunotherapy (NIR-PIT) treatment. Using ultrasound to track the microbubbles, they were able to identify areas where cancer therapy had not been fully applied.

A new vaccine recommended by independent advisers to the U.S. Centers for Disease Control and Prevention could provide more comprehensive protection from meningitis.

A new study from the University of Wisconsin–Madison suggests that chemotherapy may not be reaching its full potential, in part because researchers and doctors have long misunderstood how some of the most common cancer drugs actually ward off tumors.

Implementation of a digital risk assessment tool can identify patients with high-risk cancer susceptibility syndromes, according to a study presented at the annual meeting of the American College of Gastroenterology, held from Oct. 20 to 25 in Vancouver, British Columbia, Canada.

Worldwide, there was an increase in immunization during 2022, but coverage was lower than in 2019, according to research published in the Oct. 27 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.

Scientists have recently concluded a preclinical study that highlights the potential of SIWA318H, an advanced glycation end product (AGE)-targeting antibody, in the fight against pancreatic cancer. The results are published in Scientific Reports.

Scientists have uncovered a genetic explanation for one subset of common brain tumors, according to a study published in Nature Communications.